E M Guzmán1, C B Cha2, J D Ribeiro3, J C Franklin3. 1. Department of Counseling and Clinical Psychology, Teachers College, Columbia University, 525 West 120th Street, Box 102, New York, NY, 10027, USA. 2. Department of Counseling and Clinical Psychology, Teachers College, Columbia University, 525 West 120th Street, Box 102, New York, NY, 10027, USA. cbc2120@tc.columbia.edu. 3. Department of Psychology, Florida State University, 1107 West Call Street, Tallahasee, FL, 32306, USA.
Abstract
PURPOSE: Suicidal thoughts and behaviors (STBs) have been a persistent problem worldwide. Identifying risk factors for STBs across distinct areas of the world may help predict who or where requires the greatest attention. However, risk factors for STBs are infrequently explored cross-nationally. The present study examined whether psychopathology prospectively predicts STBs across different areas of the world, and whether certain country-level factors moderate the degree of risk conferred. METHODS: We conducted a meta-analysis of 71 longitudinal studies from 30 different countries that featured psychopathology-related variables predicting STB outcomes. Meta-regression was used to evaluate whether the following country-level factors modified risk: geographic region, income level, and degree of mental health structural stigma. RESULTS: Over 90% of studies had been conducted in North America and Europe. When assessed by country income level, it was found that only one longitudinal study on psychopathology and STB was conducted outside of a high-income country. Moreover, less than 10% of studies were conducted in high structural stigma contexts. Meta-regression findings revealed that the variation in risk effect sizes across studies was not explained by models including country-level factors. CONCLUSIONS: Our findings show critical underrepresentation of low- and middle-income countries, which account for a large proportion of global suicide deaths. This reveals a need to broaden the scope of longitudinal research on STB risk, such that countries across more regions, income levels, and degrees of structural stigma are fully accounted for. Such lines of research will improve generalizability of findings, and more precisely inform prevention efforts worldwide.
PURPOSE: Suicidal thoughts and behaviors (STBs) have been a persistent problem worldwide. Identifying risk factors for STBs across distinct areas of the world may help predict who or where requires the greatest attention. However, risk factors for STBs are infrequently explored cross-nationally. The present study examined whether psychopathology prospectively predicts STBs across different areas of the world, and whether certain country-level factors moderate the degree of risk conferred. METHODS: We conducted a meta-analysis of 71 longitudinal studies from 30 different countries that featured psychopathology-related variables predicting STB outcomes. Meta-regression was used to evaluate whether the following country-level factors modified risk: geographic region, income level, and degree of mental health structural stigma. RESULTS: Over 90% of studies had been conducted in North America and Europe. When assessed by country income level, it was found that only one longitudinal study on psychopathology and STB was conducted outside of a high-income country. Moreover, less than 10% of studies were conducted in high structural stigma contexts. Meta-regression findings revealed that the variation in risk effect sizes across studies was not explained by models including country-level factors. CONCLUSIONS: Our findings show critical underrepresentation of low- and middle-income countries, which account for a large proportion of global suicide deaths. This reveals a need to broaden the scope of longitudinal research on STB risk, such that countries across more regions, income levels, and degrees of structural stigma are fully accounted for. Such lines of research will improve generalizability of findings, and more precisely inform prevention efforts worldwide.
Authors: M A Crocq; D Naber; M H Lader; F Thibaut; M Drici; B Everitt; G C Hall; C Le Jeunne; A Mittoux; J Peuskens; S Priori; M Sturkenboom; S H L Thomas; P Tanghøj; M Toumi; R Mann; N D Moore Journal: Eur Neuropsychopharmacol Date: 2010-12 Impact factor: 4.600
Authors: Matthew K Nock; Guilherme Borges; Evelyn J Bromet; Christine B Cha; Ronald C Kessler; Sing Lee Journal: Epidemiol Rev Date: 2008-07-24 Impact factor: 6.222
Authors: Tonelle E Handley; Kerry J Inder; Brian J Kelly; John R Attia; Terry J Lewin; Michael N Fitzgerald; Frances J Kay-Lambkin Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2011-10-12 Impact factor: 4.328
Authors: Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann Journal: Am J Psychiatry Date: 2011-12 Impact factor: 18.112
Authors: Erika Dugas; Nancy C P Low; Daniel Rodriguez; Stephanie Burrows; Gisèle Contreras; Michael Chaiton; Jennifer O'Loughlin Journal: Can J Psychiatry Date: 2012-07 Impact factor: 4.356
Authors: John G Keilp; Maria A Oquendo; Barbara H Stanley; Ainsley K Burke; Thomas B Cooper; Kevin M Malone; J John Mann Journal: Neuropsychopharmacology Date: 2008-03-19 Impact factor: 7.853
Authors: Matthew K Nock; Guilherme Borges; Evelyn J Bromet; Jordi Alonso; Matthias Angermeyer; Annette Beautrais; Ronny Bruffaerts; Wai Tat Chiu; Giovanni de Girolamo; Semyon Gluzman; Ron de Graaf; Oye Gureje; Josep Maria Haro; Yueqin Huang; Elie Karam; Ronald C Kessler; Jean Pierre Lepine; Daphna Levinson; Maria Elena Medina-Mora; Yutaka Ono; José Posada-Villa; David Williams Journal: Br J Psychiatry Date: 2008-02 Impact factor: 9.319
Authors: Srinagesh Mannekote Thippaiah; Muralidhara Shankarapura Nanjappa; Suresh Bada Math Journal: Indian J Med Res Date: 2019-10 Impact factor: 2.375
Authors: Dorota Lasota; Ahmed Al-Wathinani; Paweł Krajewski; Dagmara Mirowska-Guzel; Krzysztof Goniewicz; Attila J Hertelendy; Riyadh A Alhazmi; Witold Pawłowski; Amir Khorram-Manesh; Mariusz Goniewicz Journal: Int J Environ Res Public Health Date: 2020-09-24 Impact factor: 3.390